Unique ID issued by UMIN | UMIN000057717 |
---|---|
Receipt number | R000065947 |
Scientific Title | Investigation of the relationship between ameloblastoma and salivary uric acid levels and microRNAs |
Date of disclosure of the study information | 2025/04/25 |
Last modified on | 2025/04/25 14:47:06 |
Investigation of the relationship between ameloblastoma and salivary uric acid levels and microRNAs
Uric acid levels and miRNAs in patients with ameloblastoma
Investigation of the relationship between ameloblastoma and salivary uric acid levels and microRNAs
Uric acid levels and miRNAs in patients with ameloblastoma
Japan |
ameloblastoma
Oral surgery |
Others
NO
Extract new clinical markers for ameloblastoma by identifying the relationship between ameloblastoma and uric acid levels and miRNAs associated with with cell proliferation.
Bio-availability
Salivary uric acid levels
,miRNAs associated with cell proliferation
Interventional
Parallel
Non-randomized
Open -but assessor(s) are blinded
No treatment
2
Diagnosis
Gene | Other |
Measuring salivary uric acid levels and miRNAs involved in cell proliferation in patients with ameloblastoma.
Measuring salivary uric acid levels and miRNAs involved in cell proliferation in healthy subjects.
16 | years-old | <= |
Not applicable |
Male and Female
Patient group
(1) Patients who have been diagnosed with enamel epithelioma (postoperative and scheduled surgery patients) in Department of Oral and Maxillofacial Surgery, Fukuoka Dental College Hospital.
(2) Patients who fully understand this research plan and can give informed consent by themselves or their family (parents and guardians of minors).
(3) Age 16 years or older at the time of obtaining informed consent.
Control group
(1) Patients who visit the outpatient dental clinic of Fukuoka Dental College Hospital with the main complaint of seeking dental treatment and are diagnosed as having no history of systemic diseases including ameloblastoma.
(2) Patients who fully understand this research plan and can give informed consent by themselves or their family members.
Patient group
(1) Patients who could not obtain consent.
(2) Patients who are under treatment for or have a history of malignancy including oral cancer.
(3) Other patients whom the investigator judges to be inappropriate as research subjects.
(4) When consent is withdrawn during the study.
Control group
(1) Patients who could not obtain consent.
(2) Patients who are under treatment for or have a history of malignancy including oral cancer.
(3) Other patients whom the investigator judged to be inappropriate as research subjects.
(4) In case of withdrawal of consent during the course of the study.
100
1st name | Hiromitsu |
Middle name | |
Last name | Morita |
Fukuoka Dental College
Section of Dentistry for the Disabled, Department of Oral Growth and Development
814-0193
Tamura 2-15-1, Sawara-ku, Fukuoka
092-801-0425
morita@fdcnet.ac.jp
1st name | Hiromitsu |
Middle name | |
Last name | Morita |
Fukuoka Dental College
Section of Dentistry for the Disabled, Department of Oral Growth and Development
814-0193
Tamura 2-15-1, Sawara-ku, Fukuoka
092-801-0425
morita@fdcnet.ac.jp
Fukuoka Dental College
Hiromitsu Morita
Ministry of Education, Culture, Sports, Science and Technology of Japan
Japanese Governmental office
Fukuoka Dental College
Tamura 2-15-1, Sawara-ku, Fukuoka
092-801-0425
shomu@fdcnet.ac.jp
NO
福岡歯科大学医科歯科総合病院
2025 | Year | 04 | Month | 25 | Day |
Unpublished
Enrolling by invitation
2024 | Year | 05 | Month | 10 | Day |
2024 | Year | 05 | Month | 10 | Day |
2024 | Year | 05 | Month | 10 | Day |
2026 | Year | 03 | Month | 31 | Day |
2025 | Year | 04 | Month | 25 | Day |
2025 | Year | 04 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065947